Is Pulmonary Vascular Remodeling an Intermediate Link Between Hyperglycemia and Adverse Outcomes in Patients with Idiopathic Pulmonary Arterial Hypertension? Insights from a Multi-center Cohort Study

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2024 Oct 29

PMID 39468502

Authors

Sicheng Zhang

Luyang Gao

Sicong Li

Manqing Luo

Qunying Xi

Ping Lin

Zhihui Zhao

Qing Zhao

Tao Yang

Qixian Zeng

Zhihua Huang

Xin Li

Anqi Duan

Yijia Wang

Qin Luo

Yansong Guo

Zhihong Liu

Affiliations

Soon will be listed here.

Abstract

Background: Hyperglycemia upon admission is associated with poor prognosis of many cardiovascular diseases. However, the relationship of stress hyperglycemia ratio (SHR), admission blood glucose (ABG), and hemoglobin A1c (HbA1c) with pulmonary hypertension has not been reported. This study aimed to explore the association of hyperglycemia indices with disease severity and long-term adverse outcomes in patients with idiopathic pulmonary arterial hypertension (IPAH).

Methods: This multi-center cohort study included 625 consecutive patients diagnosed with or treated for IPAH between January 2015 and June 2023. SHR was calculated using the followings: ABG (mmol/L)/(1.59 × HbA1c [%] - 2.59). The primary endpoint was defined as clinical worsening events. Multivariable Cox regression and restricted cubic spline analyses were employed to evaluate the association of SHR, ABG, and HbA1c with endpoint events. The mediating effect of pulmonary hemodynamics was evaluated to investigate the potential mechanism between hyperglycemia and clinical outcomes.

Results: During a mean follow-up period of 3.8 years, 219 (35.0%) patients experienced all-cause death or clinical worsening events. Hyperglycemia indices correlated with well-validated variables that reflected the severity of IPAH, such as the World Health Organization functional class, 6-min walk distance, and N-terminal pro-brain natriuretic peptide levels. Multivariable Cox regression analyses indicated that SHR (hazard ratio [HR] 1.328, 95% confidence intervals [CI]: 1.185, 1.489 per 0.1-unit increment, P < 0.001) and ABG (HR 1.317, 95% CI: 1.134, 1.529 per 1.0-unit increment, P < 0.001) were independent predictors of primary endpoint events. Mediation analysis indicated that pulmonary vascular resistance mediated 5.65% and 14.62% of the associations between SHR and ABG and clinical worsening events, respectively. The addition of SHR significantly improved reclassification, discrimination ability, and model fit beyond the clinical risk prediction model.

Conclusions: SHR is positively associated with clinical worsening in patients with IPAH. The association appeared to be partially mediated through the pathway of pulmonary vascular remodeling, indicating that SHR may serve as a valuable indicator for providing additional risk information.

References

Jonas K, Kurzyna M, Mroczek E, Chrzanowski L, Mularek-Kubzdela T, Skoczylas I . Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the Polish multicentre registry (BNP-PL). Cardiovasc Diabetol. 2023; 22(1):177. PMC: 10347845. DOI: 10.1186/s12933-023-01885-6. View

Cui K, Fu R, Yang J, Xu H, Yin D, Song W . The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry. Cardiovasc Diabetol. 2023; 22(1):165. PMC: 10320917. DOI: 10.1186/s12933-023-01868-7. View

Capes S, Hunt D, Malmberg K, Gerstein H . Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355(9206):773-8. DOI: 10.1016/S0140-6736(99)08415-9. View

Belly M, Tiede H, Morty R, Schulz R, Voswinckel R, Tanislav C . HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance?. J Heart Lung Transplant. 2012; 31(10):1109-14. DOI: 10.1016/j.healun.2012.08.014. View

Hoeper M, Kramer T, Pan Z, Eichstaedt C, Spiesshoefer J, Benjamin N . Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017; 50(2). DOI: 10.1183/13993003.00740-2017. View

Benza R, Miller D, Gomberg-Maitland M, Frantz R, Foreman A, Coffey C . Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010; 122(2):164-72. DOI: 10.1161/CIRCULATIONAHA.109.898122. View

Humbert M, Guignabert C, Bonnet S, Dorfmuller P, Klinger J, Nicolls M . Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2018; 53(1). PMC: 6351340. DOI: 10.1183/13993003.01887-2018. View

Chemla D, Lau E, Papelier Y, Attal P, Herve P . Pulmonary vascular resistance and compliance relationship in pulmonary hypertension. Eur Respir J. 2015; 46(4):1178-89. DOI: 10.1183/13993003.00741-2015. View

Hoeper M, Dwivedi K, Pausch C, Lewis R, Olsson K, Huscher D . Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis. Lancet Respir Med. 2022; 10(10):937-948. PMC: 9514996. DOI: 10.1016/S2213-2600(22)00097-2. View

10.

Doronzo G, Viretto M, Russo I, Mattiello L, Anfossi G, Trovati M . Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean Zucker rats. Int J Mol Sci. 2012; 13(8):9478-9488. PMC: 3431807. DOI: 10.3390/ijms13089478. View

11.

Xie E, Ye Z, Wu Y, Zhao X, Li Y, Shen N . Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study. Cardiovasc Diabetol. 2023; 22(1):288. PMC: 10612265. DOI: 10.1186/s12933-023-02036-7. View

12.

Santos S, Peinado V, Ramirez J, Morales-Blanhir J, Bastos R, Roca J . Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167(9):1250-6. DOI: 10.1164/rccm.200210-1233OC. View

13.

Tao J, Hu Z, Lou F, Wu J, Wu Z, Yang S . Higher Stress Hyperglycemia Ratio Is Associated With a Higher Risk of Stroke-Associated Pneumonia. Front Nutr. 2022; 9:784114. PMC: 8902157. DOI: 10.3389/fnut.2022.784114. View

14.

Nishikawa T, Edelstein D, Du X, Yamagishi S, Matsumura T, Kaneda Y . Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000; 404(6779):787-90. DOI: 10.1038/35008121. View

15.

Chen N, Duan D, ONeill K, Moe S . High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant. 2006; 21(12):3435-42. DOI: 10.1093/ndt/gfl429. View

16.

Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Heart J. 2015; 37(1):67-119. DOI: 10.1093/eurheartj/ehv317. View

17.

Roberts G, Quinn S, Valentine N, Alhawassi T, ODea H, Stranks S . Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio. J Clin Endocrinol Metab. 2015; 100(12):4490-7. DOI: 10.1210/jc.2015-2660. View

18.

Rosenkranz S, Preston I . Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Rev. 2015; 24(138):642-52. PMC: 9487613. DOI: 10.1183/16000617.0062-2015. View

19.

VanItallie T . Stress: a risk factor for serious illness. Metabolism. 2002; 51(6 Suppl 1):40-5. DOI: 10.1053/meta.2002.33191. View

20.

Song Y, Cui K, Yang M, Song C, Yin D, Dong Q . High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Cardiovasc Diabetol. 2023; 22(1):180. PMC: 10350280. DOI: 10.1186/s12933-023-01883-8. View